Investigational Drug Details
| Drug ID: | D466 |
| Drug Name: | Emodin |
| Synonyms: | |
| Type: | small molecule |
| DrugBank ID: | DB07715 |
| DrugBank Description: | Emodin has been investigated for the treatment of Polycystic Kidney. |
| PubChem ID: | 3220 |
| CasNo: | 518-82-1 |
| Repositioning for NAFLD: | Yes |
| SMILES: | CC1=CC(O)=C2C(=O)C3=C(C=C(O)C=C3O)C(=O)C2=C1 |
| Structure: |
|
| InChiKey: | RHMXXJGYXNZAPX-UHFFFAOYSA-N |
| Molecular Weight: | 270.2369 |
| DrugBank Targets: | Casein kinase II subunit alpha; Putative ketoacyl reductase; 3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ; Aryl hydrocarbon receptor |
| DrugBank MoA: | |
| DrugBank Pharmacology: | |
| DrugBank Indication: | |
| Targets: | |
| Therapeutic Category: | |
| Clinical Trial Progress: | |
| Latest Progress: |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted |
|---|
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|